International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 1 , Pages 164-168 , January 2010

Margin on Gross Tumor Volume and Risk of Local Recurrence in Head-and-Neck Cancer

Presented in poster form at the Annual Meeting of the American College of Radiation Oncology, February 26–28, 2009, Las Vegas, NV.

Received 20 November 2008 ,Revised 20 January 2009 ,Accepted 21 January 2009.

References 

  1. Mell LK, Mehrotra AK, Mundt AJ. Intensity-modulated radiation therapy use in the U.S., 2004. Cancer. 2005;104:1296–1303
  2. Eisbruch A, Foote RL, O'Sullivan B, et al. Intensity-modulated radiation therapy for head and neck cancer: Emphasis on the selection and delineation of the targets. Semin Radiat Oncol. 2002;12:238–249
  3. Radiation Therapy Oncology Group. RTOG 0022 protocol. Available from: http://www.rtog.org/members/protocols/h0022/h0022.pdf. Accessed October 27, 2008.
  4. Radiation Therapy Oncology Group. RTOG 0225 protocol. Available from: http://www.rtog.org/members/protocols/0225/0225.pdf. Accessed October 27, 2008.
  5. Radiation Therapy Oncology Group. RTOG 0435 protocol. Available from: http://www.rtog.org/members/protocols/0435/0435.pdf. Accessed October 27, 2008.
  6. Radiation Therapy Oncology Group. RTOG 0522 protocol. Available from: http://www.rtog.org/members/protocols/0522/0522.pdf. Accessed October 27, 2008.
  7. Radiation Therapy Oncology Group. RTOG 0615 protocol. Available from: http://www.rtog.org/members/protocols/0615/0615.pdf. Accessed October 27, 2008.
  8. Eastern Cooperative Oncology Group. ECOG 2303 protocol. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00089297. Accessed October 27, 2008.
  9. Eastern Cooperative Oncology Group. ECOG 2399 protocol. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00014118. Accessed October 27, 2008.
  10. Duan J, Shen S, Spencer SA, et al. A dynamic supraclavicular field-matching technique for head-and-neck cancer patients treated with IMRT. Int J Radiat Oncol Biol Phys. 2004;60:959–972
  11. Chao KS, Ozyigit G, Tran BN, et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2003;55:312–321
  12. Lee N, Xia P, Fischbein NJ, et al. Intensity-modulated radiation therapy for head-and-neck cancer: The UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys. 2003;57:49–60
  13. de Arruda FF, Puri DR, Zhung J, et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys. 2006;64:363–373
  14. Kwong DL, Pow EH, Sham JS, et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: A prospective study on disease control and preservation of salivary function. Cancer. 2004;101:1584–1593
  15. Yao M, Dornfeld KJ, Buatti JM, et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma: The University of Iowa experience. Int J Radiat Oncol Biol Phys. 2005;63:410–421
  16. Dawson LA, Anzai Y, Marsh L, et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2000;46:1117–1126
  17. Milano MT, Vokes EE, Kao J, et al. Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: Preliminary experience and future directions. Int J Oncol. 2006;28:1141–1151
  18. Studer G, Luetolf UM, Glanzmann C. Locoregional failure analysis in head-and-neck cancer patients treated with IMRT. Strahlenther Onkol. 2007;183:417–423
  19. Eisbruch A, Marsh LH, Dawson LA, et al. Recurrences near base of skull after IMRT for head-and-neck cancer: Implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys. 2004;59:28–42
  20. Bussels B, Maes A, Hermans R, et al. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. Radiother Oncol. 2004;72:119–127
  21. Schoenfeld GO, Amdur RJ, Morris CG, et al. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;71:377–385
  22. Garden AS, Morrison WH, Wong PF, et al. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2007;67:438–444
  23. Kwong DL, Sham JS, Leung LH, et al. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2006;64:374–381
  24. Kam MK, Teo PM, Chau RM, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60:1440–1450

 Conflict of interest: J.A.B. receives occasional honoraria from Bristol-Myers Squibb and ImClone Systems.

PII: S0360-3016(09)00133-3

doi: 10.1016/j.ijrobp.2009.01.037

International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 1 , Pages 164-168 , January 2010